Meeting
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Prognostic value of the expression of immunomodulatory targets in surgically resected lung adenocarcinoma.
Authors
Kazuya Takamochi
Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan
Kazuya Takamochi, Masaki Hosoya, Kaoru Mogushi, Takuo Hayashi, Hideya Kawaji, Yoshihide Hayashizaki, Kenji Suzuki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies
Sub Track
Immune Checkpoints and Stimulatory Receptors
Citation
J Clin Oncol 36, 2018 (suppl 5S; abstr 173)
DOI
10.1200/JCO.2018.36.5_suppl.173
Abstract #
173
Poster Bd #
L6
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Comprehensive characterization of PTPRT expression in colorectal cancer (CRC).
First Author: Francesca Battaglin
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2023 ASCO Annual Meeting
Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).
First Author: Francesca Battaglin
Poster
2023 ASCO Annual Meeting
Transforming growth factor-b1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in advanced basal cell carcinoma.
First Author: Bernardo Leon Rapoport